Finding new ways to understand and treat tumors caused by NF1 gene loss in Schwann cells

Identification of Novel Pathways Causing NF1-Driven Schwann Cell Tumors

NIH-funded research Cincinnati Childrens Hosp Med Ctr · NIH-10991410

This study is looking into how tumors develop in certain cells when a specific gene is missing, and it's aimed at finding new treatments for people affected by this condition.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCincinnati Childrens Hosp Med Ctr NIH-funded
Lab location1 site (Cincinnati, United States)
Project IDNIH-10991410 on NIH RePORTER

What this research studies

This research investigates the mechanisms behind tumors formed in Schwann cells due to the loss of the NF1 gene, which is crucial for regulating cell growth. The team will identify the proteins that interact with neurofibromin, the product of the NF1 gene, and how these interactions contribute to tumor development. Using advanced techniques in genetics and molecular biology, they will study these processes both in laboratory settings and in animal models. The ultimate goal is to explore targeted therapies that could effectively treat these tumors.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with neurofibromatosis type 1 (NF1) who are experiencing Schwann cell tumors.

Not a fit: Patients without a diagnosis of NF1 or those who do not have Schwann cell tumors may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments for patients with NF1-related Schwann cell tumors, improving their health outcomes.

How similar studies have performed: Previous research has shown promise in understanding RAS proteins and their role in tumorigenesis, suggesting that this approach could yield valuable insights.

Where this research is happening

Cincinnati, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Cancer ModelCancerModel
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.